Rx-360

Corporate consortium members are proprietary and generic pharmaceutical companies and suppliers that aim to improve the quality and security of their supply chains. Help us prevent patient safety crises, like those that occurred from adulterated glycerin used to manufacture cough syrup and teething gel that led to 67 deaths in Panama, 103 deaths in Haiti, and 40 infant deaths in Nigeria and adulterated heparin that led to 81 deaths in the United States and Europe. The globalization of distribution for both drug components and finished products has introduced many complications that are unresolved. Unethical players and noncompliant companies along the supply chain can introduce counterfeited and adulterated materials, often with tragic consequences. Legislators, regulators, and organizations around the world develop local solutions to these complex and global problems, which can be best addressed with a single global response that our consortium can deliver. Rx-360's directives are to 1) Set the Standards: The consortium scans external sources for the best available standards today with the goal for consortium members to adopt best practices with a sense of urgency; 2) Share Data: The consortium acts as a clearing house for vital supply chain information. Consortium members will report suspicious and pertinent events to the consortium, which will disseminate the information, evaluate the impact and then develop potential proactive solutions for its members to consider adopting; 3) Optimize Technology: The consortium works with partners to use technologies that prevent and detect tampering within the supply chain; 4) Encourage Audits: The consortium develops systems that make audits more thorough and allow firms to share audit findings, and corrective actions, making the system more effective & efficient.